Literature DB >> 1185538

Use of factorial design to evaluate granulations prepared by spheronization.

H J Malinowski, W E Smith.   

Abstract

This study was designed to demonstrate that properties of a granulation with a given composition, prepared by the spheronizing technique, could be altered by slight changes in process variables alone to satisfy the requirements of the formulator. A complete factorial experimental design was found satisfactory for demonstrating the range of properties to be expected and for showing statistically significant main effects and any linear interactions between selected variables. Results using two levels of five variables showed that initial water content and spheronizer speed had significant main effects on all primary granulation properties studied. While only one formulation was studied, the data suggest that the factorial design can have utility in predicting the properties of granulations prepared at conditions within the limits imposed by the equipment or formulation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185538     DOI: 10.1002/jps.2600641023

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid.

Authors:  Satishkumar P Jain; Dharmini C Mehta; Sejal P Shah; Pirthi Pal Singh; Purnima D Amin
Journal:  AAPS PharmSciTech       Date:  2010-05-25       Impact factor: 3.246

2.  Physico-mechanical characterization of the extrusion-spheronization process. Part II: Rheological determinants for successful extrusion and spheronization.

Authors:  R D Shah; M Kabadi; D G Pope; L L Augsburger
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

3.  Meltlets(®) of soy isoflavones: process optimization and the effect of extrusion spheronization process parameters on antioxidant activity.

Authors:  Ketkee Deshmukh; Purnima Amin
Journal:  Indian J Pharm Sci       Date:  2013-07       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.